Furthermore, immunostaining showed a more extensive distribution of IGF1 in cells located in oral bone marrow, bone matrix, and bone lining cells and revealed a higher number of PTH1R+IGF1+ cells under inflammatory conditions (Figure 5, L and N), providing further support for the idea that IGF1 was upregulated in inflammatory bone diseases. This evidence concerns the gene PTH1R and bone inflammation disease.